Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence

Initial license payment tied to near-term contractual delivery; additional payment opportunities may arise during development, before drug approvalPartner assumes assigned clinical and regulatory funding and execution, reducing Ainos' independent capital and staffing requirementsAinos retains exist…